Plant Biotechnology Journal · 2015 · 57 citations · 55 references
Life SciencesBiochemistryBiotechnologyAntibody EngineeringEnzymologyProtein EngineeringAntibody CharacterizationChloroplast BiochemistryRecombinant AntibodiesRecombinant Antibody ExpressionRecombinant Antibody ProductionAntigen-antibody Complex FormationChloroplast Protein TargetingEnzyme Replacement TherapyGlycogen DegradationHomologous Recombination In ChloroplastsMannose 6-Phosphate ReceptorsMannose-6-phosphate PathwayPlant-based Antibody Expression
Deficiency of acid alpha glucosidase (GAA) causes Pompe disease in which the patients systemically accumulate lysosomal glycogen in muscles and nervous systems, often resulting in infant mortality. Although enzyme replacement therapy (ERT) is effective in treating patients with Pompe disease, formation of antibodies against rhGAA complicates treatment. In this report, we investigated induction of tolerance by oral administration of GAA expressed in chloroplasts. Because full-length GAA could not be expressed, N-terminal 410-amino acids of GAA (as determined by T-cell epitope mapping) were fused with the transmucosal carrier CTB. Tobacco transplastomic lines expressing CTB-GAA were generated through site-specific integration of transgenes into the chloroplast genome. Homoplasmic lines were confirmed by Southern blot analysis. Despite low-level expression of CTB-GAA in chloroplasts, yellow or albino phenotype of transplastomic lines was observed due to binding of GAA to a chloroplast protein that has homology to mannose-6 phosphate receptor. Oral administration of the plant-made CTB-GAA fusion protein even at 330-fold lower dose (1.5 μg) significantly suppressed immunoglobulin formation against GAA in Pompe mice injected with 500 μg rhGAA per dose, with several-fold lower titre of GAA-specific IgG1 and IgG2a. Lyophilization increased CTB-GAA concentration by 30-fold (up to 190 μg per g of freeze-dried leaf material), facilitating long-term storage at room temperature and higher dosage in future investigations. This study provides the first evidence that oral delivery of plant cells is effective in reducing antibody responses in ERT for lysosomal storage disorders facilitating further advances in clinical investigations using plant cell culture system or in vitro propagation.
55
Gene splicing and mutagenesis by PCR-driven overlap extension
Karin L. Heckman, Larry R. Pease · Nature Protocols · 2007 · 1.2K citations
Biopharmaceutical benchmarks 2014
Gary Walsh · Nature Biotechnology · 2014 · 1K citations
Recombinant human acid α-glucosidase
Priya S. Kishnani, Deya Corzo, Marc Nicolino et al. · Neurology · 2006 · 772 citations · Full text